エリスロポエチン(EPO)薬の世界市場分析:薬の種類別(生物製剤、バイオシミラー)、製品別(エポエチン – アルファ、エポエチン – ベータ、ダルベポエチン – アルファ、その他)、用途別、セグメント予測、2014-2025...市場調査レポートについてご紹介

【英文タイトル】Erythropoietin (EPO) Drugs Market Analysis By Drug Class (Biologics, Biosimilars), By Product (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Others), By Application, And Segment Forecasts, 2014-2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Chapter 1 Research Methodology
1.1 Country wise market: Base estimates
1.1.1 Global market: CAGR calculation
1.1.2 Region based segment share calculation
1.2 Research Scope & Assumptions
1.3 List of Data Sources
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Erythropoietin Drugs Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.2 Market Driver Analysis
3.2.1 Increasing incidences of chronic diseases
3.2.2 Patent expiration of branded drugs
3.3 Market Restraint Analysis
3.3.1 High cost of erythropoietin drugs in developing countries
3.4 Key Opportunities Prioritized
3.4.1 Key opportunities prioritized, by product
3.5 Erythropoietin Drugs – SWOT Analysis, By Factor (political & legal, economic and technological)
3.6 Industry Analysis – Porter’s
Chapter 4 Erythropoietin Drugs Market: Drug Class Estimates & Trend Analysis
4.1 Erythropoietin Drugs Market: Drug Class Movement Analysis
4.2 Biologics
4.2.1 Biologics market, 2014 – 2025 (USD Million)
4.3 Biosimilars
4.3.1 Biosimilars market, 2014 – 2025 (USD Million)
Chapter 5 Erythropoietin Drugs Market: Product Estimates & Trend Analysis
5.1 Erythropoietin Drugs Market: Product Movement Analysis
5.2 Epoetin-alfa
5.2.1 Epoetin-alfa market, 2014 – 2025 (USD Million)
5.3 Epoetin-beta
5.3.1 Epoetin-beta market, 2014 – 2025 (USD Million)
5.4 Darbepoetin-alfa
5.4.1 Darbepoetin-alfa market, 2014 – 2025 (USD Million)
5.5 Others
5.5.1 Others market, 2014 – 2025 (USD Million)
Chapter 6 Erythropoietin Drugs Market: Application Estimates & Trend Analysis
6.1 Erythropoietin DrugsMarket: Application Movement Analysis
6.2 Cancer
6.2.1 Cancer market, 2014 – 2025 (USD Million)
6.3 Hematology
6.3.1 Hematology market, 2014 – 2025 (USD Million)
6.4 Renal Diseases
6.4.1 Renal diseases market, 2014 – 2025 (USD Million)
6.5 Neurology
6.5.1 Neurology Market, 2014 – 2025 (USD Million)
Chapter 7 Erythropoietin Drugs Market: Regional Estimates & Trend Analysis, by Drug Class, Product, and Application
7.1 Erythropoietin Drugs Market Share by Region, 2016 & 2025
7.2 North America
7.2.1 North America erythropoietin drugs market, by country, 2014 – 2025 (USD Million)
7.2.2 North America erythropoietin drugs market, by drug class, 2014 – 2025 (USD Million)
7.2.3 North America erythropoietin drugs market, by product, 2014 – 2025 (USD Million)
7.2.4 North America erythropoietin drugs market, by application, 2014 – 2025 (USD Million)
7.2.5 U.S.
7.2.5.1 U.S. erythropoietin drugs market, by drug class, 2014 – 2025 (USD Million)
7.2.5.2 U.S. erythropoietin drugs market, by product, 2014 – 2025 (USD Million)
7.2.5.3 U.S. erythropoietin drugs market, by application, 2014 – 2025 (USD Million)
7.2.6 Canada
7.2.6.1 Canada erythropoietin drugs market, by drug class, 2014 – 2025 (USD Million)
7.2.6.2 Canada erythropoietin drugs market, by product, 2014 – 2025 (USD Million)
7.2.6.3 Canada erythropoietin drugs market, by application, 2014 – 2025 (USD Million)
7.3 Europe
7.3.1 Europe erythropoietin drugs market, by country, 2014 – 2025 (USD Million)
7.3.2 Europe erythropoietin drugs market, by drug class, 2014 – 2025 (USD Million)
7.3.3 Europe erythropoietin drugs market, by product, 2014 – 2025 (USD Million)
7.3.4 Europe erythropoietin drugs market, by application, 2014 – 2025 (USD Million)
7.3.5 Germany
7.3.5.1 Germany erythropoietin drugs market, by drug class, 2014 – 2025 (USD Million)
7.3.5.2 Germany erythropoietin drugs market, by product, 2014 – 2025 (USD Million)
7.3.5.3 Germany erythropoietin drugs market, by application, 2014 – 2025 (USD Million)
7.3.6 UK
7.3.6.1 UK erythropoietin drugs market, by drug class, 2014 – 2025 (USD Million)
7.3.6.2 UK erythropoietin drugs market, by product, 2014 – 2025 (USD Million)
7.3.6.3 UK erythropoietin drugs market, by application, 2014 – 2025 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific erythropoietin drugs market, by country, 2014 – 2025 (USD Million)
7.4.2 Asia Pacific erythropoietin drugs market, by drug class, 2014 – 2025 (USD Million)
7.4.3 Asia Pacific erythropoietin drugs market, by product, 2014 – 2025 (USD Million)
7.4.4 Asia Pacific erythropoietin drugs market, by application, 2014 – 2025 (USD Million)
7.4.5 Japan
7.4.5.1 Japan erythropoietin drugs market, by drug class, 2014 – 2025 (USD Million)
7.4.5.2 Japan erythropoietin drugs market, by product, 2014 – 2025 (USD Million)
7.4.5.3 Japan erythropoietin drugs market, by application, 2014 – 2025 (USD Million)
7.4.6 China
7.4.6.1 China erythropoietin drugs market, by drug class, 2014 – 2025 (USD Million)
7.4.6.2 China erythropoietin drugs market, by product, 2014 – 2025 (USD Million)
7.4.6.3 China erythropoietin drugs market, by application, 2014 – 2025 (USD Million)
7.4.7 India
7.4.7.1 India erythropoietin drugs market, by drug class, 2014 – 2025 (USD Million)
7.4.7.2 India erythropoietin drugs market, by product, 2014 – 2025 (USD Million)
7.4.7.3 India erythropoietin drugs market, by application, 2014 – 2025 (USD Million)
7.5 Latin America
7.5.1 Latin America erythropoietin drugs market, by country, 2014 – 2025 (USD Million)
7.5.1.1 Latin America erythropoietin drugs market, by drug class, 2014 – 2025 (USD Million)
7.5.1.2 Latin America erythropoietin drugs market, by product, 2014 – 2025 (USD Million)
7.5.1.3 Latin America erythropoietin drugs market, by application, 2014 – 2025 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil erythropoietin drugs market, by drug class, 2014 – 2025 (USD Million)
7.5.2.2 Brazil erythropoietin drugs market, by product, 2014 – 2025 (USD Million)
7.5.2.3 Brazil erythropoietin drugs market, by application, 2014 – 2025 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico erythropoietin drugs market, by drug class, 2014 – 2025 (USD Million)
7.5.3.2 Mexico erythropoietin drugs market, by product, 2014 – 2025 (USD Million)
7.5.3.3 Mexico erythropoietin drugs market, by application, 2014 – 2025 (USD Million)
7.6 MEA
7.6.1 MEA erythropoietin drugs market, by country, 2014 – 2025 (USD Million)
7.6.2 MEA erythropoietin drugs market, by drug class, 2014 – 2025 (USD Million)
7.6.3 MEA erythropoietin drugs market, by product, 2014 – 2025 (USD Million)
7.6.4 MEA erythropoietin drugs market, by application, 2014 – 2025 (USD Million)
7.6.5 South Africa
7.6.5.1 South Africa erythropoietin drugs market, by drug class, 2014 – 2025 (USD Million)
7.6.5.2 South Africa erythropoietin drugs market, by product, 2014 – 2025 (USD Million)
7.6.5.3 South Africa erythropoietin drugs market, by application, 2014 – 2025 (USD Million)
Chapter 8 Competitive Landscape
8.1 Strategy Framework
8.2 Market Participation
8.3 Company Profiles
8.3.1 Johnson & Johnson
8.3.1.1 Company overview
8.3.1.2 Financial performance
8.3.1.3 Product benchmarking
8.3.1.4 Strategic initiatives
8.3.2 Celltrion, Inc.
8.3.2.1 Company overview
8.3.2.2 Financial performance
8.3.2.3 Product benchmarking
8.3.2.4 Strategic initiatives
8.3.3 Teva Pharmaceutical Industries Ltd
8.3.3.1 Company overview
8.3.3.2 Financial performance
8.3.3.3 Product benchmarking
8.3.3.4 Strategic initiatives
8.3.4 Amgen, Inc.
8.3.4.1 Company overview
8.3.4.2 Financial performance
8.3.4.3 Product benchmarking
8.3.4.4 Strategic initiatives
8.3.5 F. Hoffman-La Roche Ltd.
8.3.5.1 Company overview
8.3.5.2 Financial performance
8.3.5.3 Product benchmarking
8.3.5.4 Strategic initiatives
8.3.6 LG Life Sciences Ltd.
8.3.6.1 Company overview
8.3.6.2 Financial performance
8.3.6.3 Product benchmarking
8.3.6.4 Strategic initiatives
8.3.7 Biocon Limited
8.3.7.1 Company overview
8.3.7.2 Financial performance
8.3.7.3 Product benchmarking
8.3.7.4 Strategic initiatives
8.3.8 Intas Pharmaceuticals Ltd.
8.3.8.1 Company overview
8.3.8.2 Financial performance
8.3.8.3 Product benchmarking
8.3.8.4 Strategic initiatives
8.3.9 Sun Pharmaceutical Industries Ltd.
8.3.9.1 Company overview
8.3.9.2 Financial performance
8.3.9.3 Product benchmarking
8.3.9.4 Strategic initiatives
8.3.10 Dr. Reddy’s Laboratories Ltd.
8.3.10.1 Company overview
8.3.10.2 Financial performance
8.3.10.3 Product benchmarking
8.3.10.4 Strategic initiatives


【レポート販売概要】

■ タイトル:エリスロポエチン(EPO)薬の世界市場分析:薬の種類別(生物製剤、バイオシミラー)、製品別(エポエチン – アルファ、エポエチン – ベータ、ダルベポエチン – アルファ、その他)、用途別、セグメント予測、2014-2025
■ 英文:Erythropoietin (EPO) Drugs Market Analysis By Drug Class (Biologics, Biosimilars), By Product (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Others), By Application, And Segment Forecasts, 2014-2025
■ 発行日:2017年5月29日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707295
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。